Coya Therapeutics, Inc. — Form D
Coya Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-20. The offering totals $26.5M, of which $26.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-12-20
- Form: D
- Accession: 0001493152-23-045524
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.5M
- Amount sold: $26.5M
- Investors: 122
- Date of first sale: 2023-12-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-500218
Issuer
- Name: Coya Therapeutics, Inc.
- CIK: 0001835022
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 5850 SAN FELIPE ST., HOUSTON, TX, 77057
- Phone: 650-739-3939
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| David Snyder | Executive Officer | Philadelphia, PA |
| Dieter Weinand | Director | Philadelphia, PA |
| Hideki Garren | Director | Houston, TX |
| Anabella Villalobos | Director | Houston, TX |
| Ann Lee | Director | Houston, TX |
| Fred Grossman | Executive Officer | BIRMINGHAM, AL |
| Dov Goldstein | Director | Houston, TX |
| Wilbur Ross | Director | Houston, TX |
| Howard Berman | Director | Houston, TX |
| Howard Berman | Executive Officer | Houston, TX |
| Arun Swaminathan | Director | Houston, TX |
| Adrian Hepner | Executive Officer | Sea Ranch Lakes, FL |
| Greg MacMichael | Executive Officer | Houston, TX |
| Andrea Goldstein | Director | Houston, TX |
| Andrea Goldstein | Executive Officer | Houston, TX |
| Jani Tuomi | Director | Houston, TX |
| Shawn M Titcomb | Director | WESTON, FL |
Other filings by this issuer (3)
More